Concepedia
Statistics
Publications
16
Citations
855
H-Index
15
Active since
1988
Affiliations
Novartis (Switzerland)(Current)
Novartis Institutes for BioMedical Research
Roche (Switzerland)
University of Basel
René Hersperger is an author at Novartis (Switzerland) specializing in pharmacology, medicinal chemistry, and drug discovery.
Publications per year
1988–2019
Design and preparation of 2-benzamido-pyrimidines as inhibitors of IKK
Rudolf Waelchli, Birgit Bollbuck, Christian Bruns et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 148 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +8
A Potent and Selective S1P1 Antagonist with Efficacy in Experimental Autoimmune Encephalomyelitis
Jean Quancard, Birgit Bollbuck, Philipp Janser et al. · Chemistry & Biology · 2012 · 128 citations
Life Sciences, Neurology, Neuroscience +10
The Construction of New Proteins. Part III. Artificial folding units by assembly of amphiphilic secondary structures on a template
Manfred Mutter, Eva Altmann, Karl‐Heinz Altmann et al. · Helvetica Chimica Acta · 1988 · 92 citations
Life Sciences, Biochemistry, Biomolecular Engineering +14
Peptides as Conformational Switch: Medium‐Induced Conformational Transitions of Designed Peptides
Manfred Mutter, René Hersperger · Angewandte Chemie International Edition in English · 1990 · 83 citations
Life Sciences, Biochemistry, Protein Biochemistry +12
An allosteric MALT1 inhibitor is a molecular corrector rescuing function in an immunodeficient patient
Jean Quancard, Théo Klein, Shan‐Yu Fung et al. · Nature Chemical Biology · 2019 · 67 citations
Life Sciences, Immunology, Clinical Immunology +8
1–5 of 16